Integrated Neurology Services

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Mild cognitive impairment2 trials

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• AriBio Co., Ltd.1 trial

Running trials

• Active, not recruiting

  Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

  NCT05531526· Phase 3· AriBio Co., Ltd.· Source

Closed trials

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source